This episode of Digital Pathology Today™ our guest is Louis Culot, General Manager, Genomics and Oncology Informatics at Philips

What is going to surprise us in digital pathology in big ways and in small ways? How can seemingly small changes make a big impact in what we do as pathologists and in the lives of patients? How are we going to make use of the large datasets that we will inevitably be generating through the widescale adoption of digital pathology?

We're going to be talking about the current landscape of digital pathology in 2022, where we've been in the past 20 years and even earlier, and the impact of the COVID-19 global health emergency on the acceleration of the adoption of digital pathology. And what is the future of integrated diagnostics, incorporating digital pathology radiology and molecular diagnostics.

Louis Culot

General Manager, Genomics and Oncology Informatics

Philips

Louis Culot is General Manager of the Oncology Informatics business at Philips, where his team is leading initiatives to use informatics to better localize, characterize, and guide treatment decisions in cancer, in support of Philips mission to improve the lives of 3 billion people by 2025. Louis’ team uses advanced data modeling and analytic techniques, in combination with expert clinical guidance from leading academic medical centers, to help clinicians better understand the complexity of the disease made possible through the digital transformation of healthcare, and drive continuous improvement from early detection through treatment and follow-up care.